Study summary · 2022 · Evidence review
Interactive RPM: clinical benefits and uncertain hospital effects
Clinical endpoints improved in some pooled analyses, but hospital use and quality-of-life benefits were not established.
Summary by Vironix Health · Source review: November 11, 2026
How we select and interpret evidence
Original publication
Donato Giuseppe Leo; Benjamin J R Buckley; Mahin Chowdhury; Stephanie L Harrison; Masoud Isanejad; Gregory Y H Lip; David J Wright; Deirdre A Lane; TAILOR investigators
University of Liverpool and Liverpool Centre for Cardiovascular Science, United Kingdom
Journal of Medical Internet Research · Online: · Issue: November 2022
Journal version of record. · Full text consulted.
What was studied
- Design
- Evidence review
- Population
- People with chronic health conditions
- Sample
- 96 studies; 58 entered meta-analyses
- Intervention
- Interactive telemonitoring
- Comparator
- Usual care
- Follow-up
- Varied by study
- Review search cutoff
- 2021-02-05
- Setting
- Multiple countries
Methods
Systematic review of clinical outcomes and implementation, including randomized and nonrandomized designs; the 96 studies are not 96 randomized trials.
Findings
Mortality favored telemonitoring (RR 0.71, 95% CI 0.56–0.89). Hospitalization was inconclusive (RR 1.02, 95% CI 0.85–1.23); quality of life also showed no clear improvement.
Limitations
Blood-pressure and HbA1c analyses were highly heterogeneous. Few studies reported adherence or satisfaction. The hospitalization estimate does not demonstrate increased risk despite the authors' wording.
What this means for care delivery
Keep physiological, utilization and experience outcomes separate; positive findings in one domain cannot establish benefits in another.